RENOVORX, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
RENOVORX, INC. (RNXT) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $570.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-13
- RENOVORX, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $570.00K, a 65.22% increase year-over-year.
- RENOVORX, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $317.00K, a 10.07% increase year-over-year.
- RENOVORX, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $349.00K, a 36.86% increase year-over-year.
- RENOVORX, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $345.00K, a 41.39% increase year-over-year.
- RENOVORX, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $1.27M, a 7.92% increase from fiscal 2024.
- RENOVORX, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $1.17M, a 8.91% increase from fiscal 2023.
- RENOVORX, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $1.08M, a 71.11% increase from fiscal 2022.
- RENOVORX, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $630.00K, a 328.57% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $570.00K 10-Q · filed 2026-08-13 | $887.00K derived: sum of 2 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $317.00K 10-Q · filed 2026-08-13 | |||
| 2025-12-31 | $1.27M 10-K · filed 2026-03-30 | |||
| 2025-09-30 | $349.00K 10-Q · filed 2025-11-13 | $694.00K derived: sum of 2 quarters · filed 2026-08-13 | $982.00K derived: sum of 3 quarters · filed 2026-08-13 | |
| 2025-06-30 | $345.00K 10-Q · filed 2026-08-13 | $633.00K derived: sum of 2 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $288.00K 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | $1.17M 10-K · filed 2026-03-30 | |||
| 2024-09-30 | $255.00K 10-Q · filed 2025-11-13 | $499.00K derived: sum of 2 quarters · filed 2025-11-13 | $922.00K derived: sum of 3 quarters · filed 2025-11-13 | |
| 2024-06-30 | $244.00K 10-Q · filed 2025-11-13 | $667.00K derived: sum of 2 quarters · filed 2025-11-13 | ||
| 2024-03-31 | $423.00K 10-Q · filed 2025-11-13 | |||
| 2023-12-31 | $1.08M 10-K · filed 2025-04-01 | |||
| 2023-09-30 | $239.00K 10-Q · filed 2024-11-13 | $496.00K derived: sum of 2 quarters · filed 2024-11-13 | $740.00K derived: sum of 3 quarters · filed 2024-11-13 | |
| 2023-06-30 | $257.00K 10-Q · filed 2024-11-13 | $501.00K derived: sum of 2 quarters · filed 2024-11-13 | ||
| 2023-03-31 | $244.00K 10-Q · filed 2024-11-13 | |||
| 2022-12-31 | $630.00K 10-K · filed 2024-04-01 | |||
| 2022-09-30 | $143.00K 10-Q · filed 2023-11-13 | $312.00K derived: sum of 2 quarters · filed 2023-11-13 | $466.00K derived: sum of 3 quarters · filed 2023-11-13 | |
| 2022-06-30 | $169.00K 10-Q · filed 2023-11-13 | $323.00K derived: sum of 2 quarters · filed 2023-11-13 | ||
| 2022-03-31 | $154.00K 10-Q · filed 2023-11-13 | |||
| 2021-12-31 | $147.00K 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $6.00K 10-Q · filed 2022-11-14 | $13.00K derived: sum of 2 quarters · filed 2022-11-14 | $21.00K derived: sum of 3 quarters · filed 2022-11-14 | |
| 2021-06-30 | $7.00K 10-Q · filed 2022-11-14 | $15.00K derived: sum of 2 quarters · filed 2022-11-14 | ||
| 2021-03-31 | $8.00K 10-Q · filed 2022-11-14 | |||
| 2020-12-31 | $33.00K 10-K · filed 2022-03-30 | |||
| 2020-09-30 | $7.00K 10-Q · filed 2021-11-15 | $15.00K derived: sum of 2 quarters · filed 2021-11-15 | $25.00K derived: sum of 3 quarters · filed 2021-11-15 | |
| 2020-06-30 | $8.00K 10-Q · filed 2021-11-15 | $18.00K derived: sum of 2 quarters · filed 2021-11-15 | ||
| 2020-03-31 | $10.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |